Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.63% |
| Dec 31, 2024 | 66.02% |
| Sep 30, 2024 | -2,490.00% |
| Jun 30, 2024 | 94.97% |
| Mar 31, 2024 | 99.48% |
| Dec 31, 2023 | 58.72% |
| Dec 31, 2021 | 39.71% |
| Sep 30, 2021 | 98.30% |
| Jun 30, 2021 | 42.11% |
| Mar 31, 2020 | -84.21% |
| Dec 31, 2019 | 527.28% |
| Sep 30, 2019 | 150.82% |
| Jun 30, 2019 | -195.04% |
| Mar 31, 2019 | -26.12% |
| Dec 31, 2018 | 86.67% |
| Sep 30, 2018 | 252.91% |
| Jun 30, 2018 | 84.44% |
| Mar 31, 2018 | -52,489.69% |
| Dec 31, 2017 | 303.73% |
| Sep 30, 2017 | -1,590.54% |
| Jun 30, 2017 | 94.67% |
| Mar 31, 2017 | -105.65% |
| Dec 31, 2016 | -73.33% |
| Sep 30, 2016 | 164.10% |
| Jun 30, 2016 | 1,369.86% |
| Mar 31, 2016 | -229.90% |
| Dec 31, 2015 | 213.64% |
| Sep 30, 2015 | -244.63% |
| Jun 30, 2015 | 170.98% |
| Mar 31, 2015 | -383.83% |
| Dec 31, 2014 | -159.39% |
| Sep 30, 2014 | 100.15% |
| Jun 30, 2014 | -891.45% |
| Mar 31, 2014 | 118.59% |
| Dec 31, 2013 | -62.16% |
| Sep 30, 2013 | -307.61% |
| Jun 30, 2013 | 36.12% |
| Mar 31, 2013 | 110.57% |
| Dec 31, 2012 | -1,405,276,800.00% |
| Sep 30, 2012 | 99.95% |
| Jun 30, 2012 | 61.86% |
| Mar 31, 2012 | -100.25% |
| Dec 31, 2011 | 99,252.40% |